Second-line treatment of postmenopausal women with advanced breast carcinoma.

Authors
Board, Ruth E
Dean, Emma J
Mitchell, Claire L
Wardley, Andrew M
Affiliation
Cancer Research UK Department of Medical Oncology, Christie Hospital, Wilmslow Road, Manchester, M20 4BX, UK. ruth.board@christie-tr.nwest.nhs.uk
Issue Date
2006-04

Metadata
Show full item record
Abstract
Breast cancer is the most prevalent cancer in women and, currently, there is no standard of care for the treatment of metastatic disease. Treatment options are based on a number of tumor- and patient-related factors. This review explores some of these options, including the use of hormonal manipulation in the treatment of hormone-positive disease, current chemotherapy options and the use of targeted therapies, such as trastuzumab.
Citation
Second-line treatment of postmenopausal women with advanced breast carcinoma. 2006, 6 (4):613-24 Expert Rev Anticancer Ther
Journal
Expert Review of Anticancer Therapy
URI
http://hdl.handle.net/10541/72659
DOI
10.1586/14737140.6.4.613
PubMed ID
16613548
Type
Article
Language
en
ISSN
1744-8328
Collections